Pregabalin Capsule
Product Images NDC 80425-0124
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig 10
Fig 11
Fig 12
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6
This is a clinical study report comparing the effects of different doses of an unknown medication to placebo. The results indicate that some doses of the medication have a statistically significant effect compared to placebo. However, without further context, it is not possible to determine what the medication is for or what its potential side effects may be.*
Fig 7
Fig 9
Formula
This text represents a formula for calculating creatinine clearance (CLCr) based on age, weight, and serum creatinine levels. This formula involves subtracting the patient's age from 140, multiplying that value by their weight in kg, and then multiplying that product by 0.85 for female patients. Finally, the result is divided by 72 multiplied by the patient's serum creatinine level in mg/dL.*
Pregabalin 150mg Cap Qty 90 80425 0124
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.